Google Platform Changes Spur Pharma Rethinking Of Search Engine Ads
This article was originally published in The Tan Sheet
Executive Summary
Widespread use of paid ads that display disease-specific website address differing significantly from destination hyperlink for branded product will end in January.
You may also be interested in...
Google Creates New Formats To Include Risk Information In Sponsored Search Results
Click-through rate on health condition search results declined dramatically since FDA citations, company says.
Internet Promotions Must Be Redesigned After FDA Cites Sponsored Web Links
Firms will need to redesign sponsored links that appear on Internet search engines or forgo using them at all, food and drug attorneys suggest following the agency's recent cluster of letters citing the promotions
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.